Global Hemoglobin Testing Market Growth (Status and Outlook) 2023-2029

Global Hemoglobin Testing Market Growth (Status and Outlook) 2023-2029

Hemoglobin is a protein found in the red blood cells (RBCs) that carries out oxygen transportation throughout the body. Hemoglobin tests are carried out to measure the amount of hemoglobin present in the blood. These tests are usually performed during complete blood count as a routine health checkup or to determine the presence of any disease, which could occur due to low count of RBCs. Patients commonly undergo hemoglobin test due to reasons such as fatigue, poor health, or unexplained weight loss. The centralized hemoglobin testing methods are useful for the diagnosis of diabetes and anemia.

LPI (LP Information)' newest research report, the “Hemoglobin Testing Industry Forecast” looks at past sales and reviews total world Hemoglobin Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemoglobin Testing sales for 2023 through 2029. With Hemoglobin Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoglobin Testing industry.

This Insight Report provides a comprehensive analysis of the global Hemoglobin Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoglobin Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoglobin Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoglobin Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoglobin Testing.

The global Hemoglobin Testing market size is projected to grow from US$ 1040 million in 2022 to US$ 1572 million in 2029; it is expected to grow at a CAGR of 6.1% from 2023 to 2029.

A major factor contributing to the growth in this market is growing preference for direct-to-consumer testing. Direct-to-consumer testing is a growing trend in this market as most patients prefer home-care to laboratories. In this mode of testing, the individual does not need to visit laboratories or hospitals for tests as the laboratories send a professional person to the individual's doorstep to collect the blood sample with the help of collection devices. Once, the tests are performed, and results are received, the laboratory sends back the test results electronically to the individual. Advantages like the ease of testing and the availability of quick test results will lead to the high preference for direct-to-consumer testing during the forecast period.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemoglobin Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Chromatography
Immunoassay

Segmentation by application
Hospitals
Research Centers
Laboratories

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Abbott
Danaher
EKF Diagnostics Holdings
F. Hoffmann-La Roche

Please note: The report will take approximately 2 business days to prepare and deliver.